CelLBxHealth plc (AIM:CLBX)
London · Delayed Price · Currency is GBP · Price in GBX 1.200
+0.125 (11.63%)
At close: Jan 23, 2026
CelLBxHealth Market Cap
CelLBxHealth has a market cap or net worth of 13.64 million as of January 23, 2026. Its market cap has decreased by -61.99% in one year.
Market Cap
13.64M
Enterprise Value
12.03M
Revenue
2.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.20
Market Cap Chart
Since August 16, 2004, CelLBxHealth's market cap has decreased from 20.37M to 13.64M, a decrease of -33.05%. That is a compound annual growth rate of -1.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 13.64M | 9.09% |
| Dec 31, 2025 | 12.50M | -62.19% |
| Dec 31, 2024 | 33.06M | 8.02% |
| Dec 29, 2023 | 30.60M | -76.73% |
| Dec 30, 2022 | 131.54M | -52.97% |
| Dec 31, 2021 | 279.69M | 172.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.86B |
| GSK plc | 71.72B |
| Haleon | 33.60B |
| Smith & Nephew | 10.34B |
| Fusion Antibodies | 15.06M |
| Inspiration Healthcare Group | 12.10M |
| Oxford BioDynamics | 12.01M |
| Cambridge Cognition Holdings | 11.93M |